Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2

NCT04308668 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1312

Enrollment

OTHER

Sponsor class

Conditions

Corona Virus Infection
Acute Respiratory Distress Syndrome
SARS-CoV Infection
Coronavirus
Coronavirus Infections

Interventions

DRUG: Hydroxychloroquine
OTHER: Placebo

Sponsor

University of Minnesota

Collaborators

[object Object]
[object Object]
[object Object]